Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

GP Capital

Investor type Private Equity Firm

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 57
Average round size
info
The average size of a deal this fund participated in
$65M
Portfolio companies 51
Rounds per year 4.38
Lead investments 13
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.11
Exits 4
Key employees 1

Areas of investment

  • Manufacturing
  • Health Care
  • Medical
  • Software
  • Internet
Summary

GP Capital is the famous VC, which was founded in 2009. The main office of represented VC is situated in the Shanghai. The company was established in Asia in China.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the GP Capital, startups are often financed by ZhenFund, Samsung Ventures, Wardenclyffe Partners. The meaningful sponsors for the fund in investment in the same round are Tianxing Capital, Samsung Ventures, Qiming Venture Partners. In the next rounds fund is usually obtained by Zhangjiang Torch Venture Capital Co, ZSVC, ZJ Innopark (Zhangjiang Hi-Tech Park).

The high activity for fund was in 2019. The typical startup value when the investment from GP Capital is more than 1 billion dollars. The usual things for fund are deals in the range of more than 100 millions dollars. The fund is constantly included in 2-6 investment rounds annually. Speaking about the real fund results, this VC is 33 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2019.

The overall number of key employees were 1.

Among the most popular fund investment industries, there are Therapeutics, Robotics. Among the most popular portfolio startups of the fund, we may highlight Suning Finance, Huimin, Quanergy Systems. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of GP Capital:
Typical Co-investors
GP Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after GP Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
9Mile Labs Seattle, United States, Washington
Archimedes Labs California, Palo Alto, United States
Diverse Middle East FZE -
Ellis International Minneapolis, Minnesota, United States
Eminent Venture Capital -
Fuxi Touzi China, Ningbo, Zhejiang
Global Cardiovascular Innovation Center Cleveland, Ohio, United States
Healthcare Venture Partners Charleston, South Carolina, United States
Investment Management Corporation of Ontario Canada, Ontario, Toronto
M&L Healthcare Investments -
Mengyun Yiruan China, Shanghai
Sasken Communication Technologies Bengaluru, India, Karnataka
Shuangliang Group -
StartupXseed Ventures Bangalore, India, Karnataka
Tandem Expansion Canada, Montréal, Quebec
Tokio Marine Investment Services Japan, Tokyo
Tuode Capital -
Yitu Technology China, Shanghai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Molecular Axiom

Biopharma
Biotechnology
Medical
14 Dec 2022 China, China

Shengde Medical

Health Care
Medical
23 Nov 2022 Nanjing, Jiangsu, China

Wiseetec

Application Specific Integrated Circuit (ASIC)
Semiconductor
$15M08 Oct 2022 Suzhou, Jiangsu, China

Zefeng Semiconductor

Application Specific Integrated Circuit (ASIC)
Manufacturing
Semiconductor
04 Aug 2022 Shanghai, Shanghai, China

Shuaike Pet Food Products

Animal Feed
Food Processing
Manufacturing
Pet
$77M30 May 2022 Linyi, Shandong, China

SJ Semi

Industrial
Manufacturing
Semiconductor
$300M18 Mar 2022 Jiangyin City, Jiangsu, China

Chuangxin Huilian Technology

Electronics
Manufacturing
Mobile Devices
Telecommunications
08 Dec 2021 Nanjing, Jiangsu, China

Zendure

Consumer Electronics
Electronics
Hardware
Software
29 Nov 2021 Palo Alto, California, United States

Semitech

Industrial Automation
Industrial Manufacturing
Manufacturing
$15M22 Nov 2021 Minhang, Shanghai, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent GP Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: